TLC-ART Program

February 7, 2017

In the AIDS journal, the TLC-ART team reported that a dose of HIV drug combination, targeted to the residual virus in lymph nodes-exhibiting drug insufficiency, persisted with high levels over 2 weeks. Currently HIV patients take multiple pills daily and do not have drug levels high enough to clear the virus in the nodes. The results, improved lymph node…


August 2, 2016

The University of Washington (UW) Population Health Initiative is a 25-year program which intends to help treat disease and afflictions to improve the health and well-being of the UW community. More information can be found through the link: http://www.washington.edu/president/populationhealth/ UW President Ana Mari Cauce and Provost Jerry Baldasty announced today the selection of the 30-member Executive…


June 22, 2016

Sharon Nachman (IMPAACT Network Chair) and James McIntyre (IMPAACT Network Vice Chair) invited Dr. Rodney Ho (TLC-ART Principal Investigator) to give a 25-minute talk at the 2016 International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) Annual Meeting on April 21st, 2016. Dr. Rodney Ho (Principal Investigator) presented at the 2016 IMPAACT meeting’s plenary session on…


May 30, 2016

    Dr. Rodney Ho (TLC-ART principal investigator) presented at the 2016 BioEngage Symposium: Imaging Tools Delivering on the Promise of Precision Cancer Treatment on May 25th, 2016 at the University of Washington Foege Hall Conference Room in Seattle, WA. The University of Washington Bioengineering Department invited Dr. Ho to speak for 15 minutes on,…


March 15, 2016

Dr. Rodney Ho delivered an invited presentation at the Long-Acting/Extended Release (LA/ER) Antiretroviral Drugs Workshop at the Westin Copley Plaza Hotel in Boston, MA on February 21st, 2016. His speech, entitled “Lymphatic Targeting of combination HIV drugs– TLC ART” and sponsored by The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP), covers new strategies proven to provide…


December 27, 2015

New regimen would make it easier for patients and potentially clear residual virus Pharmaceutics Professor Rodney Ho An interdisciplinary team led by Professors Rodney JY Ho of the UW School of Pharmacy and Ann Collier of the UW School of Medicine received $14M from the National Institutes of Health (NIH) to develop a long-lasting (7-day)…